DTRT Health Acquisition Corp. (DTRT) Stock Analysis
DELISTED 2023
What happened to DTRT Health Acquisition Corp. (DTRT) stock?
DTRT Health Acquisition Corp. (DTRT) no longer trades on public markets. It was delisted in February 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
DTRT Health Acquisition Corp. (DTRT) trades at $10.34. DTRT Health Acquisition Corp. is a special purpose acquisition company (SPAC) focused on merging with a private operating business. Sector: Financial services.
Last analyzed: Mar 18, 2026Analyst Coverage for DTRT: DTRT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DTRT against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
DTRT Health Acquisition Corp. (DTRT) Financial Services Profile
DTRT Health Acquisition Corp., a special purpose acquisition company (SPAC) formed in 2021, is actively seeking a merger, asset acquisition, or other business combination within an unspecified operating business. Based in Oak Brook, Illinois, DTRT operates in the financial services sector, specifically as a shell company.
What Is the Investment Thesis for DTRT?
DTRT Health Acquisition Corp. presents a speculative investment opportunity tied to its ability to identify and complete a successful merger or acquisition. As of March 18, 2026, the company's future is entirely dependent on its ability to find a suitable target. The current P/E ratio of 29.10 reflects market expectations regarding a potential deal. Key value drivers include the management team's expertise in deal-making and their ability to identify undervalued assets. Growth catalysts are centered on the announcement and subsequent completion of a merger with a promising operating business. Potential risks include the failure to find a suitable target within the allotted timeframe, which could lead to the liquidation of the SPAC and a loss of investment for shareholders. The lack of a dividend yield further emphasizes the speculative nature of this investment.
Based on FMP financials and quantitative analysis
DTRT Key Highlights
P/E ratio of 29.10, reflecting market anticipation of a potential merger or acquisition announcement.
- No dividend yield, indicating that the company is not currently generating profits for distribution to shareholders.
- Incorporated in 2021, DTRT is still within the typical timeframe for SPACs to identify and complete a business combination.
- Based in Oak Brook, Illinois, providing access to a network of potential target companies and financial institutions.
- The company's success is entirely dependent on the management team's ability to execute a successful merger or acquisition.
Who Are DTRT's Competitors?
DTRT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DISA Disruptive Acquisition Corporation I | $10.68 | -1.66% | $91.7M | 44 |
| DSAQ Direct Selling Acquisition Corp. | $11.69 | +0.00% | $99.0M | 44 |
| GPAC Global Partner Acquisition Corp II | $10.05 | +0.10% | $238M | 44 |
| INAQ Insight Acquisition Corp. | $9.50 | -16.45% | $61.9M | 44 |
| IPXX Inflection Point Acquisition Corp. II | $10.79 | -1.78% | $91.2M | 51 |
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are DTRT's Key Strengths?
Access to capital through IPO.
- Flexibility to pursue mergers in various sectors.
- Potential for high returns if a successful merger is completed.
- Experienced management team (assumed).
What Are DTRT's Weaknesses?
No operating history or revenue generation.
- Dependent on identifying and completing a suitable merger.
- High competition in the SPAC market.
- Potential for liquidation if a merger is not completed within the allotted timeframe.
What Could Drive DTRT Stock Higher?
Announcement of a definitive merger agreement with a target company.
- Completion of the merger and subsequent public listing of the merged entity.
- Identification of potential merger targets through due diligence and market research.
- Securing financing and investor support for the merger transaction.
What Are the Key Risks for DTRT?
Negative return on equity (-78.7%) — the business is not currently generating profit on shareholder capital.
- Failure to identify a suitable merger target within the allotted timeframe, leading to liquidation.
- Regulatory changes impacting the SPAC market and increasing compliance costs.
- Market volatility and economic uncertainty affecting the valuation of potential merger targets.
- Competition from other SPACs seeking to acquire attractive companies.
- Dilution of shareholder value through the issuance of additional shares or warrants.
What Are the Growth Opportunities for DTRT?
- Successful Merger Completion: DTRT's primary growth opportunity lies in successfully identifying and completing a merger with a high-growth or strategically valuable operating business. The market size for potential targets is vast, encompassing numerous private companies across various sectors. The timeline for this opportunity is dependent on the company's ability to conduct thorough due diligence and negotiate favorable terms. A successful merger would drive significant shareholder value and establish DTRT as a viable entity in the public markets.
- Strategic Sector Focus: While DTRT has not initially specified a target sector, focusing on a particular industry with high growth potential, such as technology or healthcare, could enhance its attractiveness to investors and potential target companies. The market size within these sectors is substantial, offering numerous opportunities for mergers and acquisitions. A strategic sector focus would allow DTRT to develop expertise and a network of contacts, increasing its chances of identifying and securing a valuable target. The timeline for this opportunity is dependent on the management team's ability to identify and capitalize on emerging trends.
- Geographic Expansion: Expanding the geographic scope of its search for potential targets could provide DTRT with access to a wider range of opportunities and potentially uncover undervalued assets. The global market for private companies is vast, with numerous opportunities in emerging markets and developed economies. A geographic expansion strategy would require DTRT to develop expertise in international deal-making and navigate different regulatory environments. The timeline for this opportunity is dependent on the company's ability to establish a global network and conduct due diligence on international targets.
- Leveraging Management Expertise: DTRT can leverage the expertise and network of its management team to identify and secure a valuable target. The management team's experience in deal-making, finance, and operations can provide a competitive advantage in the SPAC market. By leveraging their expertise, DTRT can conduct thorough due diligence, negotiate favorable terms, and identify undervalued assets. The timeline for this opportunity is ongoing, as the management team continuously seeks out and evaluates potential targets.
- Capitalizing on Market Volatility: Market volatility can create opportunities for SPACs to acquire undervalued assets. During periods of economic uncertainty or market downturns, private companies may be more willing to consider mergers or acquisitions with SPACs. DTRT can capitalize on market volatility by identifying and acquiring companies that are trading at a discount to their intrinsic value. The timeline for this opportunity is dependent on market conditions and the company's ability to identify and act on emerging opportunities.
What Opportunities Does DTRT Have?
- Growing demand for alternative investment opportunities.
- Increasing number of private companies seeking to go public.
- Potential to acquire undervalued assets during market downturns.
- Strategic partnerships with industry experts and financial institutions.
What Are DTRT's Competitive Advantages?
- Management Team Expertise: A strong and experienced management team can provide a competitive advantage in identifying and securing valuable merger targets.
- Access to Capital: The capital raised through the IPO provides DTRT with the financial resources to pursue attractive acquisition opportunities.
- Speed to Market: SPACs offer a faster route to public markets for private companies compared to traditional IPOs.
- Flexibility: DTRT has the flexibility to pursue mergers with companies in various sectors.
What Does DTRT Do?
DTRT Health Acquisition Corp. was incorporated in 2021 with the primary objective of identifying and merging with an existing operating business. As a special purpose acquisition company (SPAC), DTRT does not have any significant operational history. Its sole purpose is to raise capital through an initial public offering (IPO) and subsequently use those funds to acquire or merge with a private company, effectively taking that company public. The company is based in Oak Brook, Illinois, and its activities are centered around identifying suitable target businesses. DTRT is exploring opportunities across various sectors, with no specific industry focus declared at its inception. The success of DTRT hinges on its management team's ability to identify a promising target and negotiate a favorable transaction. The ultimate goal is to create value for shareholders by bringing a high-growth or strategically important company to the public markets. DTRT's future depends entirely on the successful completion of a business combination, which will determine its long-term viability and market relevance. The company's current operations are limited to searching for potential targets and conducting due diligence on possible candidates. DTRT's competitive positioning is unique; its success is tied to identifying undervalued or high-potential companies that would benefit from becoming publicly traded.
What Products and Services Does DTRT Offer?
- DTRT Health Acquisition Corp. is a special purpose acquisition company (SPAC).
- It was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination.
- The company does not have any significant operations of its own.
- It raises capital through an initial public offering (IPO).
- The raised capital is held in trust until a target company is identified and acquired.
- DTRT's primary activity is searching for a suitable operating business to merge with.
- The goal is to take a private company public through a reverse merger.
- DTRT is based in Oak Brook, Illinois.
How Does DTRT Make Money?
- DTRT raises capital through an IPO, selling shares to public investors.
- The funds raised are held in a trust account, earning interest until a merger target is found.
- DTRT's revenue model is based on completing a successful merger, increasing the value of its shares.
- The company's sponsors typically receive a percentage of the merged company's equity as compensation.
What Industry Does DTRT Operate In?
DTRT Health Acquisition Corp. operates within the special purpose acquisition company (SPAC) industry, a segment of the financial services sector characterized by intense competition and regulatory scrutiny. SPACs serve as blank-check companies that raise capital through IPOs with the intention of merging with private companies, providing them with a faster and less regulated path to public markets compared to traditional IPOs. The SPAC market has experienced significant growth in recent years, driven by the demand for alternative investment opportunities and the desire of private companies to access public capital. However, the industry is also subject to volatility and regulatory changes, impacting the performance and viability of individual SPACs like DTRT.
Who Are DTRT's Key Customers?
- DTRT's primary customers are its shareholders, who invest in the company with the expectation of a successful merger.
- Potential target companies are also customers, as DTRT provides them with a path to becoming publicly traded.
- Investment banks and financial institutions that underwrite DTRT's IPO and advise on potential mergers.
Company Profile
DTRT Health Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Oak Brook, US. The company is led by CEO Mark S. Heaney. DTRT has traded publicly since 2021.
Key Financial Metrics
Return on equity for DTRT Health Acquisition Corp. stands at -78.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.3%, showing how much profit it generates from its asset base. DTRT trades at a trailing price-to-earnings ratio of 29.10, above the Financial Services sector average of ~18x. A current ratio of 3.88 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.4%, the inverse of the P/E and a quick read on earnings relative to price.
DTRT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that those closest to the business believe in its potential.
- Community sentiment has shifted positively as discussions around healthcare acquisition strategies gain traction, reflecting optimism among investors.
- Recent media coverage highlights the growing demand for healthcare solutions, positioning DTRT favorably in a booming sector.
- Market perception is buoyed by the increasing interest in SPACs focused on health, suggesting a favorable environment for DTRT's operations.
Bear Case
- Despite insider buying, some analysts express skepticism about the long-term viability of SPACs, which could undermine investor confidence.
- Social sentiment is mixed, with bearish voices citing concerns over the execution of acquisitions and integration challenges within the healthcare space.
- Recent developments in regulatory scrutiny of SPACs have raised caution among investors, leading to a more cautious outlook for companies like DTRT.
- Market perception remains cautious as some investors worry about the overall health of the SPAC market, which could affect DTRT's performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
DTRT Latest News
No recent news available for DTRT.
Classification
Industry Shell CompaniesLeadership: Mark S. Heaney
CEO
Mark S. Heaney serves as the CEO of DTRT Health Acquisition Corp. His background includes extensive experience in financial markets and investment management. He has held various leadership positions in investment firms, focusing on mergers and acquisitions, capital raising, and strategic planning. Mr. Heaney's expertise lies in identifying and evaluating investment opportunities across diverse sectors. He holds advanced degrees in finance and business administration, providing him with a strong foundation in financial analysis and corporate strategy.
Track Record: Under Mr. Heaney's leadership, DTRT Health Acquisition Corp. has been actively pursuing potential merger targets. His strategic decisions have focused on identifying high-growth companies with strong market potential. The company has made progress in evaluating potential candidates and conducting due diligence. However, as of March 18, 2026, a definitive agreement for a merger has not yet been announced.
DTRT Financial Services Stock FAQ
What happened to DTRT Health Acquisition Corp. (DTRT) stock?
DTRT Health Acquisition Corp. (DTRT) no longer trades on public markets. It was delisted in February 2023. The figures below are historical and are not a current quote.
Can I still buy DTRT shares?
No. DTRT stopped trading on public markets in February 2023, so the shares are not available through a broker. Anything you see quoted for DTRT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before DTRT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to DTRT Health Acquisition Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does DTRT Health Acquisition Corp. do?
DTRT Health Acquisition Corp. is a special purpose acquisition company (SPAC) formed to identify and merge with a private operating business, effectively taking that company public.
What do analysts say about DTRT stock?
As of March 18, 2026, analyst coverage of DTRT Health Acquisition Corp. is limited due to its nature as a SPAC and the absence of a definitive merger agreement. The stock's valuation is primarily driven by market expectations regarding the potential merger target and the management team's ability to execute a successful transaction.
What are the main risks for DTRT?
The primary risk for DTRT Health Acquisition Corp. is the failure to identify and complete a suitable merger within the allotted timeframe, which could lead to the liquidation of the SPAC and a loss of investment for shareholders.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- AI analysis is pending and may provide additional insights in the future.
- The company's future performance is highly dependent on its ability to complete a successful merger.